Catpagavalli Asokanathan
Research Subjects
Catpagavalli Asokanathan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Dorothy Xing
Division of Bacteriology, National Institute of Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Hertfordshire EN6 3QG, UK
4 shared publications - Michael Corbel
National Institute for Biological Standards and Control (NIBSC); South Mimms, Potters Bar, Hertfordshire UK
2 shared publications - Roland Alexander Fleck
Centre for Ultrastructural Imaging, King’s College London, London SE1 1UL, UK
2 shared publications Alex Douglas-Bardsley
National Institute for Biological Standards and Control, Potters Bar, Hertfordshire EN6 3QG, UK
1 shared publication- Barry D. Moore
Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XQ, UK
1 shared publication Chun-Ting Yuen
National Institute for Biological Standards and Control; Potters Bar, Hertfordshire, UK
1 shared publication
Latest Publications
- 1 March 2014
- Published by Elsevier in Biologicals
- Vol. 42 (2) , 101-108
An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines
- 1 March 2014
- Published by Elsevier in Biologicals
- Vol. 42 (2) , 101-108
An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines
- Open Access
- 1 February 2013
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 9 (2) , 332-338
Confocal microscopy study of pertussis toxin and toxoids on CHO-cells
Pertussis toxin in its detoxified form is a major component of all current acellular pertussis vaccines. Here we report the membrane translocation and internalization activities of pertussis toxin and various pertussis toxoids using Chinese hamster ovary cells and confocal microscopy based on indirect immunofluorescence labeling. Chemically detoxified pertussis toxoids were able to translocate/internalize into cells at the concentration about 1,000 times higher than the native toxin. Pertussis toxoids detoxified with different procedures (glutaraldehyde, glutaraldehyde plus formaldehyde, hydrogen peroxide or genetic mutation) showed differences in fluorescence intensity under the same condition, indicating toxoids from different detoxification methods may have different translocation/internalization activities on cells.
- 1 February 2013
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 9 (2) , 332-338
Open AccessConfocal microscopy study of pertussis toxin and toxoids on CHO-cells
Pertussis toxin in its detoxified form is a major component of all current acellular pertussis vaccines. Here we report the membrane translocation and internalization activities of pertussis toxin and various pertussis toxoids using Chinese hamster ovary cells and confocal microscopy based on indirect immunofluorescence labeling. Chemically detoxified pertussis toxoids were able to translocate/internalize into cells at the concentration about 1,000 times higher than the native toxin. Pertussis toxoids detoxified with different procedures (glutaraldehyde, glutaraldehyde plus formaldehyde, hydrogen peroxide or genetic mutation) showed differences in fluorescence intensity under the same condition, indicating toxoids from different detoxification methods may have different translocation/internalization activities on cells.
- Open Access
- 1 February 2013
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 9 (2) , 325-331
A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response againstBordetella pertussis
We investigated the adjuvant effect of CpG ODN alone or in combination with aluminum hydroxide on the immune response to the three main antigens presented in current acellular pertussis vaccines: pertussis toxoid, filamentous haemagglutinin and pertactin. The development of protection in mice was investigated for the intra-peritoneal and intra-nasal immunisation routes. The results showed that CpG ODN alone, or in combination with aluminum hydroxide, gave enhancement in anti-pertussis toxin, anti- filamentous haemagglutinin and especially anti-pertactin titers after mucosal immunisation. Higher macrophage NO levels indicating activation were found when the antigens were co-formulated with CpG ODN. Vaccines containing CpG ODN gave enhanced humoral and CMI responses with a shift toward Th-1 and increased protection against challenge infection with B.pertussis in mice.
- 1 February 2013
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 9 (2) , 325-331
Open AccessA CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response againstBordetella pertussis
We investigated the adjuvant effect of CpG ODN alone or in combination with aluminum hydroxide on the immune response to the three main antigens presented in current acellular pertussis vaccines: pertussis toxoid, filamentous haemagglutinin and pertactin. The development of protection in mice was investigated for the intra-peritoneal and intra-nasal immunisation routes. The results showed that CpG ODN alone, or in combination with aluminum hydroxide, gave enhancement in anti-pertussis toxin, anti- filamentous haemagglutinin and especially anti-pertactin titers after mucosal immunisation. Higher macrophage NO levels indicating activation were found when the antigens were co-formulated with CpG ODN. Vaccines containing CpG ODN gave enhanced humoral and CMI responses with a shift toward Th-1 and increased protection against challenge infection with B.pertussis in mice.